Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash Flows Used In Operating Activities:    
Net loss $ (5,038,949) $ (5,030,648)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 188,372 179,322
Share-based compensation 154,313 115,546
Foreign exchange (gain) loss 35,059 (162,028)
Transfer equipment to research and development 12,419 0
Change in equity investment in joint venture 20,239 0
Changes in working capital items:    
Accounts receivable (40,004) 84,573
Inventory (156,153) 181,316
Prepaid and other assets 36,748 235,001
Accounts payable and accrued liabilities 172,451 (302,731)
Net cash used in operating activities (4,615,505) (4,699,649)
Cash Flows From Investing Activities:    
Purchase of property, plant and equipment (382,810) (302,733)
Purchase of short-term investments (9,083,630) (5,005,607)
Proceeds on sales and maturities of short-term investments 5,000,000 7,000,000
Net cash provided by (used in) investing activities (4,466,440) 1,691,660
Cash Flows From Financing Activities:    
Proceeds from issuance of common shares, net 4,520,319 0
Payments for issuance costs (398,811) 0
Proceeds from exercise of warrants 4,650,659 0
Net cash provided by financing activities 8,772,167 0
Effect of exchange rate changes on cash and cash equivalents (35,652) 162,036
Net change in cash and cash equivalents (345,430) (2,845,953)
Cash and cash equivalents - beginning of year 4,570,951 7,416,904
Cash and cash equivalents - end of year 4,225,521 4,570,951
Cash (demand deposits) 3,719,041 3,847,655
Cash equivalents 506,480 723,296
Cash and cash equivalents 4,225,521 4,570,951
Supplemental cash flow information:    
Cash paid during the period for taxes 800 800
Supplemental disclosure of non-cash transactions:    
Issuance costs withheld from escrow proceeds 972,811 0
Fair value of placement agent warrants $ 470,912 $ 0